Page 386 - medicina-integrativa_compress

CAPÍTULO 35 RESISTENCIA A LA INSULINA Y EL SÍNDROME METABÓLICO 387

Ardawi MS: Plasma adiponectin and insulin resistance in women with Lawlor DA: Avoiding milk is associated with a reduced risk of insulin
polycystic ovary syndrome. Fertil Steril 83:1708-1716, 2005. resistance and the metabolic syndrome: Findings from the British
Bautista MC: The Mediterranean diet: Is it cardioprotective? Prog Women’s Heart and Health Study. Diabet Med 22:808-811, 2005.
Cardiovasc Nurs 20:70-76, 2005. Lee YH: The evolving role of inflammation in obesity and the metabolic
Bertraos S, Meyeme-Ondoua JP, et al: Sedentary behaviors, physical syndrome. Curr Diab Rep 5:70-75, 2005.
activity, and metabolic syndrome in middle-aged French subjects. Li WL, Zheng HC: Natural medicines used in the traditional Chinese
Obes Res 13:936-944, 2005. medical system for therapy of diabetes mellitus. J Ethnopharmacol
Bonora E, Kiechl S, Willeit J, et al: Carotid atherosclerosis and coronary 92:1- 21, 2004. A systematic review of 80 Chinese herbs, including
heart disease in the metabolic syndrome: Prospective data from the traditional uses and research.
Bruneck study. Diabetes Care 26:1251-1257, 2003. Lindstrom J, Louheranta A, Mannelin M, et al: The Finnish Diabetes
Boule NG: Physical fitness and the metabolic syndrome in adults from the Prevention Study (DPS): Lifestyle intervention and 3-year results on
Quebec Family Study. Can J Appl Physiol 30:140-156, 2005. diet and physical activity. Diabetes Care 26:3230-3236, 2003.
Cheng TO: All teas are not created equal: The Chinese green tea and Lteif AA: Obesity, insulin resistance, and the metabolic syndrome:
cardiovascular health. Int J Cardiol 108:301-308, 2005. Determinants of endothelial dysfunction in whites and blacks.
Davis J: Soy protein influences the development of the metabolic Circulation 112:32-38, 2005.
syndrome in male obese ZDFxSHHF rats. Horm Metab Res Mackin P, Watkinson HM, Young AH: Prevalence of obesity, glucose
37:316-325, 2005. homeostasis disorders and metabolic syndrome in psychiatric
Deedwania PC: Current treatment options for the metabolic syndrome. patients taking typical or atypical antipsychotic drugs: A
Curr Treat Options Cardiovasc Med 7:61-74, 2005. cross-sectional study. Diabetologia 48:215-221, 2005.
Dey L, Attele AS, Yuan CS: Alternative therapy for type II diabetes. Alt Matfin G: Erectile dysfunction: Interrelationship with the metabolic
Med Rev 7:45-58, 2002. syndrome. Curr Diab Rep 5:64-69, 2005.
Elder C: Ayurveda for diabetes mellitus: A review of the biomedical Mendez-Sanchez N: Metabolic syndrome as a risk factor for gallstone
literature. Altern Ther Health Med 10:44-50, 2004. A review disease. World J Gastroenterol 11:1653-1657, 2005.
of the English language literature related to Ayurveda and Meyers CD, Kashyap ML: Management of the metabolic
diabetes care, encompassing herbs, diet, yoga, and meditation as syndrome-nicotinic acid. Endocrinol Metab Clin North Am 33:
modalities that are accessible and acceptable to Western clinicians and 557-575, 2004.
patient. Miranda PJ: Metabolic syndrome: Evaluation of pathological and
Esmaillzadeh A: Whole-grain consumption and the metabolic therapeutic outcomes. Am Heart J 149:20-32, 2005.
syndrome: A favorable association in Tehranian adults. Eur J Clin Mittendorfer B: Insulin resistance: Sex matters. Curr Opin Clin Nutr
Nutr 59:353-362, 2005. Metab Care 8:367-372, 2005.
Esposito K: The metabolic syndrome: A cause of sexual dysfunction in Mobbs CV: Impaired glucose signaling as a cause of obesity and the
women. Int J Impot Res 17:224-226, 2005. metabolic syndrome: The glucoadipostatic hypothesis. Physiol Behav
Esposito K: Obesity, the metabolic syndrome, and sexual dysfunction. 85:3-23, 2005.
Int J Impot Res 17:391-398, 2005. Molnar D, Decsi T, Koletzko B: Reduced antioxidant status in obese
Evans JL: The molecular basis for oxidative stress-induced insulin children with multimetabolic syndrome. Int J Obes Relat Metab
resistances. Antioxid Redox Signal 7:1040-1045, 2005. Disord 28:1197-1202, 2004.
Ford ES: Concentrations of serum vitamin D and the metabolic syndrome Nakanishi N: Cigarette smoking and the risk of the metabolic
among US adults. Diabetes Care 28:1228-1230, 2005. syndrome in middle-aged Japanese male office workers. Ind Health
Ford ES: Sedentary behavior, physical activity, and the metabolic 43:295-301, 2005.
syndrome among U.S. adults. Obes Res 13:608-614, 2005. Nieuwdorp M: Hypercoagulability in the metabolic syndrome.
Fornoni A: Metabolic syndrome and endothelial dysfunction. Curr Curr Opin Pharmacol 5:155-159, 2005.
Hypertens Rep 7:88-95, 2005. Orchard TJ: The effect of metformin and intensive lifestyle intervention
Frisbee JC: Reduced nitric oxide bioavailability contributes to skeletal on the metabolic syndrome: The Diabetes Prevention Program
muscle microvessel rarefaction in the metabolic syndrome. Am J randomized trial. Ann Intern Med 142:611-619, 2005.
Physiol Regul Integr Comp Physiol 289:R307-R316, 2005. Ozata M, Oktenli C, Bingol N, Ozdemir IC: The effects of metformin and
Glucose tolerance and mortality: Comparison of WHO and American diet on plasma testosterone and leptin levels in obese men. Obes Res
Diabetes Association diagnostic criteria. The DECODE study group. 9:662-667, 2001.
European Diabetes Epidemiology Group. Diabetes Epidemiology: Parish R: Mitochondrial dysfunction and type 2 diabetes. Curr Diab Rep
Collaborative analysis of diagnostic criteria in Europe. Lancet 5:177-183, 2005.
354:617-621, 1999. Plomgaard P: TNF-alpha, but not IL-6, stimulates plasminogen activator
Gonzalez-Sanchez JL: An SNP in the adiponectin gene is associated with inhibitor-1 expression in human subcutaneous adipose tissue.
decreased serum adiponectin levels and risk for impaired glucose J Appl Physiol 98:2019-2023, 2005.
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
tolerance. Obes Res 13:807-812, 2005. Pritchett AM: Treatment of the metabolic syndrome: The impact of
Han TS, Sattar N, Williams K, et al: Prospective study of C-reactive lifestyle modification. Curr Atheroscler Rep 7:95-102, 2005.
protein in relation to the development of diabetes and metabolic Reynolds K: Metabolic syndrome: Underrated or underdiagnosed?
syndrome in the Mexico City Diabetes Study. Diabetes Care Diabetes Care 28:1831-1832, 2005.
25:2016-2021, 2002. Saexna A, Vikram NK: Role of selected Indian plants in management
Higashiura K: Magnesium and insulin resistance. Clin Calcium of type 2 diabetes: A review. J Altern Complement Med 10:369-378,
15:251-254, 2005. 2004. Discusses herbs, such as Momordica charantia, Pterocarpus
Huang TH: Herbal or natural medicines as modulators of peroxisome marsupium, and Trigonella foenum-graecum, that have been
proliferator-activated receptors and related nuclear receptors for reported to be beneficial.
therapy of metabolic syndrome. Basic Clin Pharmacol Sethi JK, Vidal-Puig A: Visfatin: The missing link between intra-
Toxicol 96:3-14, 2005. abdominal obesity and diabetes? Trends Mol Med 11:344-347, 2005.
Kadowaki T: Adiponectin and adiponectin receptors. Endocr Rev Setola E, Monti LD, Galluccio E, et al: Insulin resistance and endothelial
26:439-451, 2005. function are improved after folate and vitamin B12 therapy in
Kelly GS: Insulin resistance: Lifestyle and nutritional interventions. patients with metabolic syndrome: Relationship between
Altern Med Rev 5:109-132, 2000. homocysteine levels and hyperinsulinemia. Eur J Endocrinol
Knowler WC, Barrett-Connor E, Fowler SE, et al: Reduction in the 151:483-489, 2004.
incidence of type 2 diabetes with lifestyle intervention or metformin. Shimosawa T: Adrenomedullin as a potent antioxidative and
N Engl J Med 346:393-403, 2002. antiatherosclerotic substance. Timely Top Med Cardiovasc
LaMonte MJ, Barlow CE, Jurca R, et al: Cardiorespiratory fitness is Dis 1:9, 2005.
inversely associated with the incidence of metabolic Sola S, Mir MQ, Cheema FA, et al: Irbesartan and lipoic acid
syndrome: A prospective study of men and women. Circulation improve endothelial function and reduce markers of inflammation
112:453-455, 2005. in the metabolic syndrome: Results of the Irbesartan and Lipoic
Lau DC: Adipokines: Molecular links between obesity and atherosclerosis. Acid in Endothelial Dysfunction (ISLAND) study. Circulation
Am J Physiol Heart Circ Physiol 288:H2031-2041, 2005. 111:343-348, 2005.